menu

ReachMD

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Managing to an LDL-P Goal within Existing Therapeutic Strategies

Dr. Cromwell examines the 2013 AHA/ACC cholesterol management guidelines and LDL-P and apo B targets of therapy supported by various experts.
  • Sponsored by

  • Overview

    The 2013 AHA/ACC cholesterol management guidelines prioritized therapies based on the proven benefit in treatment populations. However, as clinicians know, individual patient response to therapy varies. Optimizing individual patient care requires identification of an individual’s LDL response to therapy and, as indicated, adjustment in therapy to achieve improved LDL reduction. 

    Dr. William Cromwell, medical director for cardiovascular disease at LabCorp, will review LDL-P and apo B targets of therapy that are supported by various expert organizations, as well as agents that reduce particle production and improve particle clearance.

    Click here to learn more in this special series.

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.